Coinjection of amyloid β peptide(25-35) and ibotenic acid does not create an animal model for Alzheimer's disease.

被引：0
|
作者：
Laksafoss, T [1 ]
Jorgensen, OS [1 ]
机构：
[1] Rigshosp 6102, Lab Neuropsychiat, DK-2100 Copenhagen, Denmark
来源：
EUROPEAN JOURNAL OF NEUROSCIENCE | 1998年 / 10卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
3232
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [21] Cognitive-enhancing activities of the polyprenol preparation Ropren® in gonadectomized β-amyloid (25-35) rat model of Alzheimer's disease
    Fedotova, Julia
    Soultanov, Vagif
    Nikitina, Tamara
    Roschin, Victor
    Ordyan, Natalia
    Hritcu, Lucian
    PHYSIOLOGY & BEHAVIOR, 2016, 157 : 55 - 62
  • [22] Cholesterol inhibits the insertion of the Alzheimer's peptide Aβ(25-35) in lipid bilayers
    Dante, Silvia
    Hauss, Thomas
    Dencher, Norbert A.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2006, 35 (06): : 523 - 531
  • [23] Characterization of Changes due to pH Variations in Beta Peptide (25-35) Leading to Alzheimer's Disease
    Senthil, Rethinam
    Srividya, S.
    Aruni, A. Wilson
    Basaran, Bahri
    Jyotsna
    Thirugnanasambandam, Rajendran
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2020, 26 (04) : 1863 - 1870
  • [24] Effect of Indigofera tinctoria on β-amyloid (25-35) mediated Alzheimer's disease in mice: Relationship to antioxidant activity
    Balamurugan, G.
    Muralidharan, P.
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2010, 5 (01) : 51 - 56
  • [25] Gene Expression Profile of Hippocampus in Aβ (25-35) Induced Alzheimer's Disease Model Rat
    Huang, F. J.
    Tian, X. X.
    Li, W. P.
    Li, Y. H.
    Shen, J. G.
    Wu, Z. Z.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 : S341 - S341
  • [26] Vaccination with Aβ peptide prevents cognitive deficits in an animal model of Alzheimer's disease.
    Sorondo, JP
    Diamond, D
    Hatcher, J
    Austin, L
    Gottschall, P
    Gordon, M
    Morgan, D
    Arendash, G
    FASEB JOURNAL, 2001, 15 (04): : A67 - A67
  • [27] Antidepressant-Like Effect of RoprenA® in β-Amyloid-(25-35) Rat Model of Alzheimer's Disease with Altered Levels of Androgens
    Soultanov, Vagif
    Fedotova, Julia
    Nikitina, Tamara
    Roschin, Victor
    Ordyan, Natalia
    Hritcu, Lucian
    MOLECULAR NEUROBIOLOGY, 2017, 54 (04) : 2611 - 2621
  • [28] Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25-35
    Kaminsky, Yury G.
    Marlatt, Michael W.
    Smith, Mark A.
    Kosenko, Elena A.
    EXPERIMENTAL NEUROLOGY, 2010, 221 (01) : 26 - 37
  • [29] Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A beta 25-35
    Hope, J
    Shearman, MS
    Baxter, HC
    Chong, A
    Kelly, SM
    Price, NC
    NEURODEGENERATION, 1996, 5 (01): : 1 - 11
  • [30] Okadaic acid modulates the cytoskeleton changes induced by amyloid peptide (25-35) in cultured astrocytes
    Salinero, O
    MorenoFlores, MT
    Wandosell, F
    NEUROREPORT, 1997, 8 (15) : 3333 - 3338
12345